{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:44:33Z","timestamp":1790711073316,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41390-022-02152-2","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T09:03:42Z","timestamp":1655197422000},"page":"541-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of synthetic surfactant (CHF5633) bolus and\/or lavage in meconium-induced lung injury in ventilated newborn rabbits"],"prefix":"10.1038","volume":"93","author":[{"given":"Yaling","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2152_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000369373","volume":"107","author":"PH Lindenskov","year":"2015","unstructured":"Lindenskov, P. H., Castellheim, A., Saugstad, O. D. & Mollnes, T. E. Meconium aspiration syndrome: possible pathophysiological mechanisms and future potential therapies. Neonatology 107, 225\u2013230 (2015).","journal-title":"Neonatology"},{"key":"2152_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.siny.2017.04.002","volume":"22","author":"NE Vain","year":"2017","unstructured":"Vain, N. E. & Batton, D. G. Meconium \u201caspiration\u201d (or respiratory distress associated with meconium-stained amniotic fluid?). Semin. Fetal Neonatal Med. 22, 214\u2013219 (2017).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"2152_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/archdischild-2012-302524","volume":"98","author":"B Sun","year":"2013","unstructured":"Sun, B., Shao, X., Cao, Y., Xia, S. & Yue, H. Neonatal-perinatal medicine in a transitional period of China. Arch. Dis. Child. Fetal Neonatal Ed. 98, 440\u2013444 (2013).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2152_CR4","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1542\/peds.2011-0725","volume":"129","author":"H Wang","year":"2012","unstructured":"Wang, H. et al. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. Pediatrics 129, e731\u2013e740 (2012).","journal-title":"Pediatrics"},{"key":"2152_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/adc.63.4.368","volume":"63","author":"PI Macfarlane","year":"1988","unstructured":"Macfarlane, P. I. & Heaf, D. P. Pulmonary function in children after neonatal meconium aspiration syndrome. Arch. Dis. Child. 63, 368\u2013372 (1988).","journal-title":"Arch. Dis. Child."},{"key":"2152_CR6","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1038\/jp.2008.154","volume":"28","author":"N Beligere","year":"2008","unstructured":"Beligere, N. & Rao, R. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review. J. Perinatol. 28, S93\u2013S101 (2008).","journal-title":"J. Perinatol."},{"key":"2152_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/pr.2015.265","volume":"79","author":"J Kopincova","year":"2016","unstructured":"Kopincova, J. & Calkovska, A. Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms. Pediatr. Res. 79, 514\u2013521 (2016).","journal-title":"Pediatr. Res."},{"key":"2152_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1542\/peds.97.1.48","volume":"97","author":"RD Findlay","year":"1996","unstructured":"Findlay, R. D., Taeusch, H. W. & Walther, F. J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97, 48\u201352 (1996).","journal-title":"Pediatrics"},{"key":"2152_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","volume":"132","author":"A Lotze","year":"1998","unstructured":"Lotze, A. et al. H. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in term infants study group. J. Pediatr. 132, 40\u201347 (1998).","journal-title":"J. Pediatr."},{"key":"2152_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1651-2227.2005.tb02008.x","volume":"94","author":"Chinese Collaborative Study Group for Neonatal Respiratory Diseases.","year":"2005","unstructured":"Chinese Collaborative Study Group for Neonatal Respiratory Diseases. Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre, randomized, controlled trial. Acta Paediatr. 94, 896\u2013902 (2005).","journal-title":"Acta Paediatr."},{"key":"2152_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1542\/peds.109.6.1081","volume":"109","author":"TE Wiswell","year":"2002","unstructured":"Wiswell, T. E. et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 109, 1081\u20131087 (2002).","journal-title":"Pediatrics"},{"key":"2152_CR12","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/jp.2008.163","volume":"28","author":"J Gadzinowski","year":"2008","unstructured":"Gadzinowski, J., Kowalska, K. & Vidyasagar, D. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO. J. Perinatol. 28, S56\u2013S66 (2008).","journal-title":"J. Perinatol."},{"key":"2152_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jpeds.2010.08.044","volume":"158","author":"PA Dargaville","year":"2011","unstructured":"Dargaville, P. A. et al. Randomized controlled trial of lung lavage with dilute surfactant for meconium aspiration syndrome. J. Pediatr. 158, 383\u2013389 (2011).","journal-title":"J. Pediatr."},{"key":"2152_CR14","doi-asserted-by":"publisher","first-page":"e217269","DOI":"10.1001\/jamanetworkopen.2021.7269","volume":"4","author":"P Challis","year":"2021","unstructured":"Challis, P., Nydert, P., H\u00e5kansson, S. & Norman, M. Association of adherence to surfactant best practice uses with clinical outcomes among neonates in Sweden. JAMA Netw. Open 4, e217269 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2152_CR15","first-page":"CD002054","volume":"2014","author":"AI El. Shahed.","year":"2014","unstructured":"El. Shahed., A. I., Dargaville, P. A., Ohlsson, A. & Soll, R. Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst. Rev. 2014, CD002054 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2152_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000243917","volume":"63","author":"B Sun","year":"1993","unstructured":"Sun, B., Curstedt, T., Song, G. W. & Robertson, B. Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol. Neonate 63, 96\u2013104 (1993).","journal-title":"Biol. Neonate"},{"key":"2152_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1152\/jappl.1994.77.4.1961","volume":"77","author":"B Sun","year":"1994","unstructured":"Sun, B., Herting, E., Curstedt, T. & Robertson, B. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. J. Appl. Physiol. 77, 1961\u20131971 (1994).","journal-title":"J. Appl. Physiol."},{"key":"2152_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1164\/ajrccm.154.3.8810617","volume":"154","author":"B Sun","year":"1996","unstructured":"Sun, B., Curstedt, T. & Robertson, B. Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am. J. Respir. Crit. Care Med. 154, 764\u2013770 (1996).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2152_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1164\/rccm.200301-121OC","volume":"168","author":"PA Dargaville","year":"2003","unstructured":"Dargaville, P. A. et al. Therapeutic lung lavage in the piglet model of meconium aspiration syndrome. Am. J. Respir. Crit. Care Med. 168, 456\u2013463 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2152_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00431-007-0596-7","volume":"167","author":"A Calkovska","year":"2008","unstructured":"Calkovska, A., Mokra, D., Drgova, A., Zila, I. & Javorka, K. Bronchoalveolar lavage with pulmonary surfactant\/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome. Eur. J. Pediatr. 167, 851\u2013857 (2008).","journal-title":"Eur. J. Pediatr."},{"key":"2152_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/pr.2016.203","volume":"81","author":"S Sardesai","year":"2017","unstructured":"Sardesai, S., Biniwale, M., Wertheimer, F., Garingo, A. & Ramanathan, R. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr. Res. 81, 240\u2013248 (2017).","journal-title":"Pediatr. Res."},{"key":"2152_CR22","first-page":"CD003486","volume":"4","author":"S Hahn","year":"2013","unstructured":"Hahn, S., Choi, H. J., Soll, R. & Dargaville, P. A. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst. Rev. 4, CD003486 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2152_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/joim.12845","volume":"285","author":"J Johansson","year":"2019","unstructured":"Johansson, J. & Curstedt, T. Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases. J. Intern. Med. 285, 165\u2013186 (2019).","journal-title":"J. Intern. Med."},{"key":"2152_CR24","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1183\/09031936.97.10091967","volume":"10","author":"B Sun","year":"1997","unstructured":"Sun, B. et al. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur. Respir. J. 10, 1967\u20131974 (1997).","journal-title":"Eur. Respir. J."},{"key":"2152_CR25","doi-asserted-by":"publisher","first-page":"e39392","DOI":"10.1371\/journal.pone.0039392","volume":"7","author":"A Sato","year":"2012","unstructured":"Sato, A. & Ikegami, M. SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung. PLoS ONE 7, e39392 (2012).","journal-title":"PLoS ONE"},{"key":"2152_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/pr.2016.231","volume":"81","author":"F Ricci","year":"2017","unstructured":"Ricci, F., Murgia, X., Razzetti, R., Pelizzi, N. & Salomone, F. In vitro and in vivo comparison between Poractant alfa and the new generation synthetic surfactant CHF5633. Pediatr. Res. 81, 369\u2013375 (2017).","journal-title":"Pediatr. Res."},{"key":"2152_CR27","doi-asserted-by":"publisher","first-page":"e47631","DOI":"10.1371\/journal.pone.0047631","volume":"7","author":"M Seehase","year":"2012","unstructured":"Seehase, M. et al. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. PLoS ONE 7, e47631 (2012).","journal-title":"PLoS ONE"},{"key":"2152_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14787210.2017.1259067","volume":"15","author":"K Glaser","year":"2017","unstructured":"Glaser, K. et al. Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes. Expert Rev. Antiinfect. Ther. 15, 181\u2013189 (2017).","journal-title":"Expert Rev. Antiinfect. Ther."},{"key":"2152_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000356065","volume":"105","author":"B Salvesen","year":"2014","unstructured":"Salvesen, B., Curstedt, T., Mollnes, T. E. & Saugstad, O. D. Effects of natural versus synthetic surfactant with SP-B and SP-C analogs in a porcine model of meconium aspiration syndrome. Neonatology 105, 128\u2013135 (2014).","journal-title":"Neonatology"},{"key":"2152_CR30","doi-asserted-by":"publisher","first-page":"e14700","DOI":"10.14814\/phy2.14700","volume":"9","author":"P Mikolka","year":"2021","unstructured":"Mikolka, P. et al. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome. Physiol. Rep. 9, e14700 (2021).","journal-title":"Physiol. Rep."},{"key":"2152_CR31","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/archdischild-2017-312722","volume":"102","author":"DG Sweet","year":"2017","unstructured":"Sweet, D. G. et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch. Dis. Child. Fetal Neonatal Ed. 102, 1497\u20131503 (2017).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2152_CR32","doi-asserted-by":"publisher","unstructured":"Sweet, D. G. et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. J. Matern. Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2020.1863363 (2020).","DOI":"10.1080\/14767058.2020.1863363"},{"key":"2152_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpeds.2020.06.024","volume":"225","author":"R Ramanathan","year":"2020","unstructured":"Ramanathan, R. et al. Synthetic surfactant CHF5633 compared with Poractant alfa in the treatment of neonatal respiratory distress syndrome: a multicenter, double-blind, randomized, controlled clinical trial. J. Pediatr. 225, 90\u201396 (2020).","journal-title":"J. Pediatr."},{"key":"2152_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41390-019-0421-9","volume":"86","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Dong, Y., Guo, X. & Sun, B. Suppression of pulmonary group B streptococcal proliferation and translocation by surfactants in ventilated near-term newborn rabbits. Pediatr. Res. 86, 208\u2013215 (2019).","journal-title":"Pediatr. Res."},{"key":"2152_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1152\/japplphysiol.00027.2021","volume":"131","author":"S Luo","year":"2021","unstructured":"Luo, S. et al. Comparison of survival of preterm newborn rabbits at 25-28 days of gestation with perinatal therapies at birth transition. J. Appl. Physiol. 131, 220\u2013228 (2021).","journal-title":"J. Appl. Physiol."},{"key":"2152_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1183\/09031936.93.04030364","volume":"4","author":"B Sun","year":"1991","unstructured":"Sun, B. et al. Application of a new ventilator-multi- plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur. Respir. J. 4, 364\u2013370 (1991).","journal-title":"Eur. Respir. J."},{"key":"2152_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","volume":"234","author":"GR Bartlett","year":"1959","unstructured":"Bartlett, G. R. Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466\u2013468 (1959).","journal-title":"J. Biol. Chem."},{"key":"2152_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0022-2275(20)36986-8","volume":"17","author":"RJ Mason","year":"1976","unstructured":"Mason, R. J., Nellenbogen, J. & Clements, J. A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17, 281\u2013284 (1976).","journal-title":"J. Lipid Res."},{"key":"2152_CR39","first-page":"CD004477","volume":"7","author":"SR Lewis","year":"2019","unstructured":"Lewis, S. R., Pritchard, M. W., Thomas, C. M. & Smith, A. F. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst. Rev. 7, CD004477 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2152_CR40","first-page":"CD000144","volume":"8","author":"S Ardell","year":"2015","unstructured":"Ardell, S., Pfister, R. H. & Soll, R. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst. Rev. 8, CD000144 (2015).","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02152-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T15:08:44Z","timestamp":1678115324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02152-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02152-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported by Chiesi Farmaceutici S.p.A, which owns the marketing rights for Poractant alfa and patent rights of CHF5633. F.R. and F.S. are Chiesi Farmaceutici employees. X.M. is a Chiesi consultant. The company contributed to the study design but had neither influence on the performance, analysis, and interpretation of experimental data nor in writing the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient consent was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}